{"id":4135,"date":"2021-11-22T13:49:39","date_gmt":"2021-11-22T13:49:39","guid":{"rendered":"https:\/\/vygonwp.cekom.de\/?post_type=hub_landingpages&#038;p=4135"},"modified":"2022-11-15T13:48:12","modified_gmt":"2022-11-15T13:48:12","slug":"onkologie-seite","status":"publish","type":"hub_landingpages","link":"https:\/\/www.vygon.de\/unternehmen\/anwendungen\/onkologie-seite\/","title":{"rendered":"Onkologie-Seite"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8220;1&#8243; custom_padding_last_edited=&#8220;on|tablet&#8220; next_background_color=&#8220;#ffffff&#8220; admin_label=&#8220;Hero&#8220; _builder_version=&#8220;4.16&#8243; use_background_color_gradient=&#8220;on&#8220; background_color_gradient_direction=&#8220;170deg&#8220; background_color_gradient_stops=&#8220;rgba(0,46,79,0.28) 1%|rgba(8,70,102,0.39) 100%&#8220; background_color_gradient_overlays_image=&#8220;on&#8220; background_color_gradient_start=&#8220;rgba(0,46,79,0.28)&#8220; background_color_gradient_start_position=&#8220;1%&#8220; background_color_gradient_end=&#8220;rgba(8,70,102,0.39)&#8220; background_image=&#8220;https:\/\/www.vygon.de\/unternehmen\/wp-content\/uploads\/2021\/11\/AdobeStock_212192827_verlauf.jpg&#8220; background_position=&#8220;top_right&#8220; custom_padding=&#8220;110px|0px|160px|0px|false|false&#8220; custom_padding_tablet=&#8220;50px||50px||true&#8220; custom_padding_phone=&#8220;|||&#8220; bottom_divider_style=&#8220;ramp&#8220; bottom_divider_height=&#8220;125px&#8220; bottom_divider_flip=&#8220;horizontal&#8220; bottom_divider_height_tablet=&#8220;90px&#8220; bottom_divider_height_phone=&#8220;80px&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_row _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_de_mach_carousel post_type_choose=&#8220;landingpages&#8220; loop_layout=&#8220;3999&#8243; custom_tax_choose=&#8220;landingpage_category&#8220; include_taxomony=&#8220;Onkologie&#8220; posts_number_desktop=&#8220;1&#8243; posts_number_tablet=&#8220;1&#8243; posts_number_tablet_land=&#8220;1&#8243; enable_arrows=&#8220;off&#8220; enable_dots=&#8220;on&#8220; dot_color=&#8220;#FFFFFF&#8220; dot_color_active=&#8220;#7CDA24&#8243; autoplay_speed=&#8220;4000&#8243; infinate=&#8220;on&#8220; _builder_version=&#8220;4.17.0&#8243; _module_preset=&#8220;default&#8220; excerpt_text_color=&#8220;#FFFFFF&#8220; transform_translate=&#8220;-50px|0px&#8220; transform_translate_linked=&#8220;off&#8220; text_orientation=&#8220;left&#8220; module_alignment=&#8220;left&#8220; custom_margin=&#8220;||0px|0px|false|false&#8220; custom_padding=&#8220;||0px|0px|false|false&#8220; title_font_size_tablet=&#8220;&#8220; title_font_size_phone=&#8220;14px&#8220; title_font_size_last_edited=&#8220;on|desktop&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_de_mach_carousel][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8220;1_4,1_4,1_4,1_4&#8243; use_custom_gutter=&#8220;on&#8220; gutter_width=&#8220;2&#8243; admin_label=&#8220;Features&#8220; _builder_version=&#8220;4.16&#8243; custom_margin=&#8220;30px|||&#8220; custom_width_px=&#8220;1280px&#8220; global_colors_info=&#8220;{}&#8220; disabled_on=&#8220;on|on|on&#8220; disabled=&#8220;on&#8220;][et_pb_column type=&#8220;1_4&#8243; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;|||&#8220; global_colors_info=&#8220;{}&#8220; custom_padding__hover=&#8220;|||&#8220;][et_pb_video src=&#8220;https:\/\/www.youtube.com\/watch?v=T-47k4VXWbI&#8220; image_src=&#8220;\/\/i.ytimg.com\/vi\/T-47k4VXWbI\/hqdefault.jpg&#8220; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_video][et_pb_text _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; text_text_color=&#8220;#FFFFFF&#8220; text_font_size=&#8220;14px&#8220; global_colors_info=&#8220;{}&#8220;]<strong>SICHERHEITSSYSTEM F\u00dcR DIE APPLIKATION TOXISCHER ARZNEIMITTEL (SCHWERKRAFTINFUSION)<\/strong><br \/>\n[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8220;1_4&#8243; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;|||&#8220; global_colors_info=&#8220;{}&#8220; custom_padding__hover=&#8220;|||&#8220;][et_pb_video src=&#8220;https:\/\/youtu.be\/bEQJBuQsn3k&#8220; image_src=&#8220;\/\/i.ytimg.com\/vi\/bEQJBuQsn3k\/hqdefault.jpg&#8220; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_video][et_pb_text _builder_version=&#8220;4.17.0&#8243; _module_preset=&#8220;default&#8220; text_text_color=&#8220;#FFFFFF&#8220; text_font_size=&#8220;14px&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p><strong>SICHERHEITSSYSTEM F\u00dcR DIE APPLIKATION TOXISCHER ARZNEIMITTEL (INFUSIONSPUMPE)<\/strong><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8220;1_4&#8243; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;|||&#8220; global_colors_info=&#8220;{}&#8220; custom_padding__hover=&#8220;|||&#8220;][\/et_pb_column][et_pb_column type=&#8220;1_4&#8243; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;|||&#8220; global_colors_info=&#8220;{}&#8220; custom_padding__hover=&#8220;|||&#8220;][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; module_id=&#8220;zertifikate&#8220; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; custom_padding=&#8220;11px||9px|||&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_row _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; custom_padding=&#8220;||6px|||&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; saved_specialty_column_type=&#8220;2_3&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Poppins|600|||||||&#8220; text_text_color=&#8220;gcid-d08e7a08-b747-4a4e-bec9-6f46a3c29f19&#8243; text_orientation=&#8220;center&#8220; custom_margin=&#8220;||0px||false|false&#8220; global_colors_info=&#8220;{%22gcid-d08e7a08-b747-4a4e-bec9-6f46a3c29f19%22:%91%22text_text_color%22%93}&#8220;]Dokumente<br \/>\n[\/et_pb_text][et_pb_divider color=&#8220;gcid-d08e7a08-b747-4a4e-bec9-6f46a3c29f19&#8243; divider_weight=&#8220;4px&#8220; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; width=&#8220;100%&#8220; module_alignment=&#8220;center&#8220; custom_margin=&#8220;0px||0px||false|false&#8220; custom_padding=&#8220;0px||0px||false|false&#8220; global_colors_info=&#8220;{%22gcid-d08e7a08-b747-4a4e-bec9-6f46a3c29f19%22:%91%22color%22%93}&#8220;][\/et_pb_divider][et_pb_text _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; header_3_font=&#8220;Open Sans||||||||&#8220; header_3_text_color=&#8220;gcid-f7280f3d-17cc-4d2a-9e34-a7b8316cf68e&#8220; header_3_font_size=&#8220;25px&#8220; header_3_line_height=&#8220;1.3em&#8220; text_orientation=&#8220;center&#8220; header_3_font_tablet=&#8220;&#8220; header_3_font_phone=&#8220;&#8220; header_3_font_last_edited=&#8220;on|phone&#8220; global_colors_info=&#8220;{%22gcid-f7280f3d-17cc-4d2a-9e34-a7b8316cf68e%22:%91%22header_3_text_color%22,%22header_3_text_color%22%93}&#8220;]<\/p>\n<h3>hier direkt herunterladen<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8220;1_2,1_2&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; custom_padding=&#8220;15px|||||&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;1_2&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][dsm_icon_list icon_color=&#8220;gcid-29fd1057-87a9-4597-87d4-1964dc9ebb67&#8243; _builder_version=&#8220;4.17.0&#8243; _module_preset=&#8220;default&#8220; text_text_color=&#8220;gcid-29fd1057-87a9-4597-87d4-1964dc9ebb67&#8243; global_colors_info=&#8220;{%22gcid-29fd1057-87a9-4597-87d4-1964dc9ebb67%22:%91%22icon_color%22,%22text_text_color%22%93}&#8220; icon_background_color__hover_enabled=&#8220;off|desktop&#8220;][dsm_icon_list_child text=&#8220;Klinische Evidenz CSSA&#8220; icon_background_color=&#8220;#FFFFFF&#8220; icon_padding=&#8220;4px&#8220; icon_font_size=&#8220;57px&#8220; url=&#8220;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9hdHRhY2htZW50Iiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjQxNDIifX0=@&#8220; _builder_version=&#8220;4.17.0&#8243; _dynamic_attributes=&#8220;url&#8220; _module_preset=&#8220;default&#8220; text_font=&#8220;|600|||||||&#8220; text_text_color=&#8220;gcid-29fd1057-87a9-4597-87d4-1964dc9ebb67&#8243; text_font_size=&#8220;18px&#8220; global_colors_info=&#8220;{%22gcid-29fd1057-87a9-4597-87d4-1964dc9ebb67%22:%91%22text_text_color%22,%22text_text_color%22,%22icon_background_color%22,%22text_text_color%22%93}&#8220;]<strong><a href=\"https:\/\/www.vygon.de\/index.php\/fuseaction\/download\/lrn_file\/ce_z-18-04316e_iso-13485_2018_20181016.pdf\">ECM Deutschland &#8211; ISO 13485<\/a><\/strong><br \/>\n[\/dsm_icon_list_child][\/dsm_icon_list][\/et_pb_column][et_pb_column type=&#8220;1_2&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][dsm_icon_list icon_color=&#8220;gcid-29fd1057-87a9-4597-87d4-1964dc9ebb67&#8243; _builder_version=&#8220;4.17.0&#8243; _module_preset=&#8220;default&#8220; text_text_color=&#8220;gcid-29fd1057-87a9-4597-87d4-1964dc9ebb67&#8243; global_colors_info=&#8220;{%22gcid-29fd1057-87a9-4597-87d4-1964dc9ebb67%22:%91%22icon_color%22,%22text_text_color%22%93}&#8220; icon_background_color__hover_enabled=&#8220;off|desktop&#8220;][dsm_icon_list_child text=&#8220;Studie_Qimono_Wirksamkeit_des_Sp\u00fclens&#8220; icon_background_color=&#8220;#FFFFFF&#8220; icon_padding=&#8220;4px&#8220; icon_font_size=&#8220;57px&#8220; url=&#8220;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9hdHRhY2htZW50Iiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjM3MDUifX0=@&#8220; _builder_version=&#8220;4.17.0&#8243; _dynamic_attributes=&#8220;url&#8220; _module_preset=&#8220;default&#8220; text_font=&#8220;|600|||||||&#8220; text_text_color=&#8220;gcid-29fd1057-87a9-4597-87d4-1964dc9ebb67&#8243; text_font_size=&#8220;18px&#8220; global_colors_info=&#8220;{%22gcid-29fd1057-87a9-4597-87d4-1964dc9ebb67%22:%91%22text_text_color%22,%22text_text_color%22,%22icon_background_color%22,%22text_text_color%22%93}&#8220;]<strong><a href=\"https:\/\/www.vygon.de\/index.php\/fuseaction\/download\/lrn_file\/ce_z-18-04316e_iso-13485_2018_20181016.pdf\">ECM Deutschland &#8211; ISO 13485<\/a><\/strong><br \/>\n[\/dsm_icon_list_child][\/dsm_icon_list][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; admin_label=&#8220;Services&#8220; _builder_version=&#8220;4.16&#8243; display_conditions=&#8220;W10=&#8220; custom_padding=&#8220;20px|0px|20px|0px|true|false&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_row _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_de_mach_carousel post_type_choose=&#8220;landingpages&#8220; loop_layout=&#8220;3862&#8243; posts_number=&#8220;5&#8243; custom_tax_choose=&#8220;landingpage_category&#8220; include_taxomony=&#8220;Onkologie&#8220; posts_number_desktop=&#8220;3&#8243; posts_number_tablet=&#8220;3&#8243; equal_height=&#8220;off&#8220; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; title_font_size=&#8220;18px&#8220; excerpt_font_size=&#8220;16px&#8220; custom_margin=&#8220;|0px||0px|false|false&#8220; custom_padding=&#8220;|0px||0px|false|false&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_de_mach_carousel][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; custom_padding_last_edited=&#8220;on|desktop&#8220; admin_label=&#8220;Offer&#8220; _builder_version=&#8220;4.16&#8243; background_color=&#8220;#FFFFFF&#8220; use_background_color_gradient=&#8220;on&#8220; background_color_gradient_type=&#8220;circular&#8220; background_color_gradient_direction_radial=&#8220;right&#8220; background_color_gradient_stops=&#8220;rgba(0,46,79,0.13) 0%|rgba(8,70,102,0.8) 50%&#8220; background_color_gradient_overlays_image=&#8220;on&#8220; background_color_gradient_start=&#8220;rgba(0,46,79,0.13)&#8220; background_color_gradient_end=&#8220;rgba(8,70,102,0.8)&#8220; background_color_gradient_end_position=&#8220;50%&#8220; background_image=&#8220;https:\/\/www.vygon.de\/unternehmen\/wp-content\/uploads\/2021\/06\/AdobeStock_216606410-farbl.jpg&#8220; module_alignment=&#8220;right&#8220; custom_margin=&#8220;|||0%&#8220; custom_margin_tablet=&#8220;|||0%&#8220; custom_margin_last_edited=&#8220;off|desktop&#8220; custom_padding=&#8220;10vw|0px||0px|false|false&#8220; custom_padding_tablet=&#8220;40px|||&#8220; custom_padding_phone=&#8220;&#8220; top_divider_style=&#8220;asymmetric3&#8243; top_divider_color=&#8220;#FFFFFF&#8220; top_divider_height=&#8220;100%&#8220; top_divider_repeat=&#8220;0.6x&#8220; top_divider_flip=&#8220;vertical&#8220; top_divider_height_tablet=&#8220;90px&#8220; top_divider_height_phone=&#8220;90px&#8220; top_divider_height_last_edited=&#8220;on|phone&#8220; bottom_divider_height=&#8220;50px&#8220; animation_style=&#8220;slide&#8220; animation_direction=&#8220;bottom&#8220; animation_intensity_slide=&#8220;4%&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_row column_structure=&#8220;1_3,2_3&#8243; custom_padding_last_edited=&#8220;on|desktop&#8220; _builder_version=&#8220;4.16&#8243; max_width=&#8220;80%&#8220; custom_margin=&#8220;|||&#8220; custom_margin_tablet=&#8220;|||10%&#8220; custom_margin_last_edited=&#8220;off|desktop&#8220; custom_padding=&#8220;200px|0px||16%|false|false&#8220; custom_padding_tablet=&#8220;|||0%&#8220; custom_padding_phone=&#8220;|||&#8220; use_custom_width=&#8220;on&#8220; width_unit=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;1_3&#8243; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;|||&#8220; global_colors_info=&#8220;{}&#8220; custom_padding__hover=&#8220;|||&#8220;][et_pb_text _builder_version=&#8220;4.17.0&#8243; text_font=&#8220;Open Sans|600||on|||||&#8220; text_font_size=&#8220;22px&#8220; header_font=&#8220;||||||||&#8220; header_2_font=&#8220;Open Sans|600|||||||&#8220; header_2_font_size=&#8220;4vw&#8220; header_2_line_height=&#8220;0.9em&#8220; header_6_font=&#8220;Montserrat|700|||||||&#8220; header_6_font_size=&#8220;30px&#8220; header_6_line_height=&#8220;1.5em&#8220; background_layout=&#8220;dark&#8220; max_width=&#8220;500px&#8220; animation_style=&#8220;zoom&#8220; animation_intensity_zoom=&#8220;20%&#8220; header_2_font_size_tablet=&#8220;180px&#8220; header_2_font_size_phone=&#8220;1.6em&#8220; header_2_font_size_last_edited=&#8220;on|tablet&#8220; header_3_font_size_tablet=&#8220;&#8220; header_3_font_size_phone=&#8220;&#8220; header_3_font_size_last_edited=&#8220;on|phone&#8220; header_2_text_shadow_style=&#8220;preset5&#8243; header_2_text_shadow_horizontal_length=&#8220;0.03em&#8220; header_2_text_shadow_vertical_length=&#8220;0.03em&#8220; header_2_text_shadow_color=&#8220;rgba(40,101,150,0.5)&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p>in Deutschland<\/p>\n<h2>492.000<\/h2>\n<h3 class=\"title\">KREBSERKRANKUNGEN <span id=\"cmfSimpleFootnoteLink1-0\" class=\"cmf_has_footnote_custom\"><sup><a href=\"#cmfSimpleFootnoteLink1\" class=\"et_smooth_scroll_disabled cmf_simple_footnote_link show-tooltip type1\" title =\"Neue Zahlen zu Krebs in Deutschland\r\nPressemitteilung des Robert Koch-Instituts, Stand: 17.12.2019\" data-extlink=\"\" data-extlink_label=\"\">1<\/a><\/sup><\/span><\/h3>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8220;2_3&#8243; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;|||&#8220; global_colors_info=&#8220;{}&#8220; custom_padding__hover=&#8220;|||&#8220;][et_pb_text _builder_version=&#8220;4.16&#8243; text_font=&#8220;Montserrat||||||||&#8220; text_font_size=&#8220;16px&#8220; header_font=&#8220;||||||||&#8220; header_2_font=&#8220;Open Sans|700|||||||&#8220; header_2_font_size=&#8220;40px&#8220; header_2_line_height=&#8220;1.4em&#8220; header_6_font=&#8220;Montserrat|600||on|||||&#8220; header_6_font_size=&#8220;16px&#8220; header_6_letter_spacing=&#8220;2px&#8220; header_6_line_height=&#8220;1.5em&#8220; background_layout=&#8220;dark&#8220; max_width=&#8220;600px&#8220; custom_margin=&#8220;|||&#8220; header_2_font_size_tablet=&#8220;&#8220; header_2_font_size_phone=&#8220;24px&#8220; header_2_font_size_last_edited=&#8220;on|phone&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h6>SICHERHEIT<\/h6>\n<h2>QIMONO sch\u00fctzt vor EXPOSITIONEN<\/h2>\n<p>Mit dem steigenden Einsatz von Zytostasen, auch f\u00fcr Indikationen au\u00dferhalb der Onkologie (z.B. rheumatische Erkrankungen), erh\u00f6ht sich auch das Expositionsrisiko f\u00fcr Mitarbeiter im Gesundheitswesen.<br \/>\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_row _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; text_orientation=&#8220;center&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h3><strong>Anforderungen an ein sicheres Applikationssystem<\/strong><\/h3>\n<p>[\/et_pb_text][et_pb_image src=&#8220;https:\/\/www.vygon.de\/unternehmen\/wp-content\/uploads\/2021\/11\/Qimono-Vorteile-2.jpg&#8220; alt=&#8220;Qimono-Vorteile und Anforderungen&#8220; title_text=&#8220;Qimono-Vorteile und Anforderungen&#8220; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_image][et_pb_text _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; text_orientation=&#8220;center&#8220; global_colors_info=&#8220;{}&#8220;]Qimono macht das bestehende Infusionssystem sicherer, da es mit Standard Luer-Lock Systemen kompatibel ist und sowohl patientenseitig als auch infusionsseitig ein jederzeit geschlossenes System ist.<br \/>\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; background_color=&#8220;rgba(255,255,255,0.76)&#8220; background_image=&#8220;https:\/\/www.vygon.de\/unternehmen\/wp-content\/uploads\/2021\/10\/onkologie-frau-background.jpg&#8220; background_blend=&#8220;lighten&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_row column_structure=&#8220;1_2,1_2&#8243; use_custom_gutter=&#8220;on&#8220; module_class=&#8220;two-columns&#8220; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; custom_padding=&#8220;||||false|false&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;1_2&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; custom_padding=&#8220;||||false|false&#8220; custom_padding_tablet=&#8220;&#8220; custom_padding_phone=&#8220;|10px||10px|false|false&#8220; custom_padding_last_edited=&#8220;on|phone&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_image src=&#8220;https:\/\/www.vygon.de\/unternehmen\/wp-content\/uploads\/2021\/10\/Qimono_maennlich-weiblich.jpg&#8220; title_text=&#8220;Qimono_maennlich-weiblich&#8220; align=&#8220;center&#8220; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; max_width=&#8220;400px&#8220; max_height=&#8220;1000px&#8220; custom_margin=&#8220;||10px||false|false&#8220; animation_style=&#8220;zoom&#8220; animation_intensity_zoom=&#8220;8%&#8220; border_radii=&#8220;on|100%|100%|100%|100%&#8220; border_width_all=&#8220;8px&#8220; border_color_all=&#8220;gcid-29fd1057-87a9-4597-87d4-1964dc9ebb67&#8243; box_shadow_style=&#8220;preset1&#8243; box_shadow_color=&#8220;gcid-f7411942-e938-4a6f-abb9-df4175b605e9&#8243; animation=&#8220;off&#8220; global_colors_info=&#8220;{%22gcid-29fd1057-87a9-4597-87d4-1964dc9ebb67%22:%91%22border_color_all%22%93,%22gcid-f7411942-e938-4a6f-abb9-df4175b605e9%22:%91%22box_shadow_color%22%93,%22gcid-d08e7a08-b747-4a4e-bec9-6f46a3c29f19%22:%91%93}&#8220; filter_saturate__hover_enabled=&#8220;on|hover&#8220; filter_saturate__hover=&#8220;53%&#8220;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8220;1_2&#8243; _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; custom_padding=&#8220;||||false|false&#8220; custom_padding_tablet=&#8220;&#8220; custom_padding_phone=&#8220;|10px||10px|false|false&#8220; custom_padding_last_edited=&#8220;on|phone&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; text_text_color=&#8220;gcid-29fd1057-87a9-4597-87d4-1964dc9ebb67&#8243; text_font_size=&#8220;30px&#8220; custom_margin=&#8220;0px||10px||false|false&#8220; global_colors_info=&#8220;{%22gcid-d08e7a08-b747-4a4e-bec9-6f46a3c29f19%22:%91%93,%22gcid-29fd1057-87a9-4597-87d4-1964dc9ebb67%22:%91%22text_text_color%22%93}&#8220;]Qimono Produkte<br \/>\n[\/et_pb_text][et_pb_text _builder_version=&#8220;4.17.0&#8243; _module_preset=&#8220;default&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p>Das Qimono Sicherheitsapplikationssystem ist ein sog. Closed Safety System for Administration (CSSA), das\u00a0 individuelle Sicherheitsl\u00f6sungen f\u00fcr den Umgang mit gesundheitsgef\u00e4hrdenden Substanzen bietet um die Mitarbeiter in der Klinik oder Ambulanz sowie Patienten und deren Angeh\u00f6rige vor den schwerwiegenden Folgen einer Zytostatika-Exposition \u00a0bestm\u00f6glich zu sch\u00fctzen. <span id=\"cmfSimpleFootnoteLink2-0\" class=\"cmf_has_footnote_custom\"><sup><a href=\"#cmfSimpleFootnoteLink2\" class=\"et_smooth_scroll_disabled cmf_simple_footnote_link show-tooltip type1\" title =\"Seth Eisenberg, Closed safety system for administration (CSSA): proposal for a new cytotoxic chemotherapy acronym, British Journal of Nursing, 2022, Vol 31, No 10 (Oncology Supplement)\" data-extlink=\"\" data-extlink_label=\"\">2<\/a><\/sup><\/span><\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8220;https:\/\/vygon-frontend.cekom.de\/infusionstherapie\/infusionszubehor\/infusionssysteme-onkologie-cstd\/qimono&#8220; button_text=&#8220;Produkte&#8220; button_alignment=&#8220;left&#8220; _builder_version=&#8220;4.17.0&#8243; _module_preset=&#8220;default&#8220; button_text_size=&#8220;26px&#8220; button_bg_color=&#8220;gcid-29fd1057-87a9-4597-87d4-1964dc9ebb67&#8243; button_bg_use_color_gradient=&#8220;on&#8220; button_bg_color_gradient_stops=&#8220;#268ea8 0%|#5798a8 100%&#8220; button_bg_color_gradient_start=&#8220;#268ea8&#8243; button_bg_color_gradient_end=&#8220;#5798a8&#8243; button_border_width=&#8220;0px&#8220; custom_margin=&#8220;0px||0px||false|false&#8220; custom_padding=&#8220;||||false|false&#8220; button_text_size_tablet=&#8220;&#8220; button_text_size_phone=&#8220;20px&#8220; button_text_size_last_edited=&#8220;on|phone&#8220; global_colors_info=&#8220;{%22gcid-29fd1057-87a9-4597-87d4-1964dc9ebb67%22:%91%22button_bg_color%22,%22colorStart%22,%22button_bg_color%22,%22colorStart%22,%22button_bg_color%22%93,%22gcid-f7411942-e938-4a6f-abb9-df4175b605e9%22:%91%93}&#8220;][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; admin_label=&#8220;Shop&#8220; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;0|0px|54px|0px|false|false&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_row _builder_version=&#8220;4.16&#8243; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.16&#8243; custom_padding=&#8220;|||&#8220; global_colors_info=&#8220;{}&#8220; custom_padding__hover=&#8220;|||&#8220;][et_pb_text _builder_version=&#8220;4.16&#8243; text_font=&#8220;Montserrat||||||||&#8220; text_font_size=&#8220;16px&#8220; link_font=&#8220;Montserrat|700|||||||&#8220; link_text_color=&#8220;#fa546d&#8220; link_font_size=&#8220;22px&#8220; link_line_height=&#8220;1.5em&#8220; ul_font=&#8220;||||||||&#8220; header_font=&#8220;||||||||&#8220; header_2_font=&#8220;Open Sans|700|||||||&#8220; header_2_font_size=&#8220;40px&#8220; header_2_line_height=&#8220;1.4em&#8220; header_6_font=&#8220;Montserrat|600||on|||||&#8220; header_6_text_color=&#8220;#24d9e2&#8243; header_6_font_size=&#8220;16px&#8220; header_6_letter_spacing=&#8220;2px&#8220; header_6_line_height=&#8220;1.5em&#8220; text_orientation=&#8220;center&#8220; max_width=&#8220;700px&#8220; max_width_last_edited=&#8220;off|desktop&#8220; module_alignment=&#8220;center&#8220; custom_margin=&#8220;|||&#8220; custom_padding=&#8220;|||&#8220; header_2_font_size_tablet=&#8220;&#8220; header_2_font_size_phone=&#8220;24px&#8220; header_2_font_size_last_edited=&#8220;on|phone&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<h2>Empfohlene Produkte<\/h2>\n<p>[\/et_pb_text][et_pb_code _builder_version=&#8220;4.16&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;]\n<script>\n\/\/  window.loadMagentoProductsRoute = 'https:\/\/vygon-api.cekom.de\/products?skus=';\n\/\/  window.loadMagentoProductsRoute = 'https:\/\/vygon-api.cekom.de\/products?skus=10001,10002&catid=6'\n  window.loadMagentoProductsRoute = 'https:\/\/vygon-api.cekom.de\/products?skus=&catid=311'\n\/\/  window.loadMagentoProductsRoute = 'https:\/\/vygon-api.cekom.de\/products?sku=10323'\n<\/script>\n  <link href=\"https:\/\/www.vygon.de\/unternehmen\/wp-content\/plugins\/magento_products\/VygonProductSlider\/dist\/css\/app.8dd12db5.css\" rel=\"preload\" as=\"style\">\n  <link href=\"https:\/\/www.vygon.de\/unternehmen\/wp-content\/plugins\/magento_products\/VygonProductSlider\/dist\/css\/app.8dd12db5.css\" rel=\"stylesheet\">\n\n  <link href=\"https:\/\/www.vygon.de\/unternehmen\/wp-content\/plugins\/magento_products\/VygonProductSlider\/dist\/js\/app.0f767114.js\" rel=\"preload\" as=\"script\">  \n  <link href=\"https:\/\/www.vygon.de\/unternehmen\/wp-content\/plugins\/magento_products\/VygonProductSlider\/dist\/js\/chunk-vendors.f926f10c.js\" rel=\"preload\" as=\"script\">  \n\n<div id=\"app\"><\/div>\n\n<script src=\"https:\/\/www.vygon.de\/unternehmen\/wp-content\/plugins\/magento_products\/VygonProductSlider\/dist\/js\/app.0f767114.js\"><\/script>\n<script src=\"https:\/\/www.vygon.de\/unternehmen\/wp-content\/plugins\/magento_products\/VygonProductSlider\/dist\/js\/chunk-vendors.f926f10c.js\"><\/script>\n\n[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n<div class=\"pg-ft-sep\"><div class=\"sep-brdr\" style=\"width:25%; border-bottom:1px solid #000;\"><\/div><\/div><div id=\"cmfSimpleFootnoteDefinitionBox\"><div class=\"cmfSimpleFootnoteDefinitionItem cmfSimpleFootnoteLink1\"><span class=\"cmfSimpleFootnoteDefinitionItemId\" id=\"cmfSimpleFootnoteLink1\">1<a href=\"#cmfSimpleFootnoteLink1-0\" class=\"cm-footnote-backlink et_smooth_scroll_disabled\">\u2191<\/a> <\/span><span class=\"cmfSimpleFootnoteDefinitionItemContent\">Neue Zahlen zu Krebs in Deutschland\r\nPressemitteilung des Robert Koch-Instituts, Stand: 17.12.2019<\/span> <a class=\"cm_footnote_extlink\" href=\"\"><\/a><\/div><div class=\"cmfSimpleFootnoteDefinitionItem cmfSimpleFootnoteLink2\"><span class=\"cmfSimpleFootnoteDefinitionItemId\" id=\"cmfSimpleFootnoteLink2\">2<a href=\"#cmfSimpleFootnoteLink2-0\" class=\"cm-footnote-backlink et_smooth_scroll_disabled\">\u2191<\/a> <\/span><span class=\"cmfSimpleFootnoteDefinitionItemContent\">Seth Eisenberg, Closed safety system for administration (CSSA): proposal for a new cytotoxic chemotherapy acronym, British Journal of Nursing, 2022, Vol 31, No 10 (Oncology Supplement)<\/span> <a class=\"cm_footnote_extlink\" href=\"\"><\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>SICHERHEITSSYSTEM F\u00dcR DIE APPLIKATION TOXISCHER ARZNEIMITTEL (SCHWERKRAFTINFUSION) SICHERHEITSSYSTEM F\u00dcR DIE APPLIKATION TOXISCHER ARZNEIMITTEL (INFUSIONSPUMPE)Dokumente hier direkt herunterladen <div class=\"et_pb_module dsm_icon_list dsm_icon_list_0\">\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t<div class=\"et_pb_module_inner\">\n\t\t\t\t\t<ul class=\"dsm_icon_list_items dsm_icon_list_ltr_direction dsm_icon_list_layout_vertical\"><li class=\"dsm_icon_list_child dsm_icon_list_child_0\">\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t<span class=\"dsm_icon_list_wrapper\"><span class=\"dsm_icon_list_icon\">P<\/span><\/span><span class=\"dsm_icon_list_text\">Klinische Evidenz CSSA<\/span>\n\t\t\t<\/li><\/ul>\n\t\t\t\t<\/div>\n\t\t\t<\/div><div class=\"et_pb_module dsm_icon_list dsm_icon_list_1\">\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t<div class=\"et_pb_module_inner\">\n\t\t\t\t\t<ul class=\"dsm_icon_list_items dsm_icon_list_ltr_direction dsm_icon_list_layout_vertical\"><li class=\"dsm_icon_list_child dsm_icon_list_child_1\">\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t<span class=\"dsm_icon_list_wrapper\"><span class=\"dsm_icon_list_icon\">P<\/span><\/span><span class=\"dsm_icon_list_text\">Studie_Qimono_Wirksamkeit_des_Sp\u00fclens<\/span>\n\t\t\t<\/li><\/ul>\n\t\t\t\t<\/div>\n\t\t\t<\/div>in Deutschland 492.000 KREBSERKRANKUNGEN <span id=\"cmfSimpleFootnoteLink1-0\" class=\"cmf_has_footnote_custom\"><sup><a href=\"#cmfSimpleFootnoteLink1\" class=\"et_smooth_scroll_disabled cmf_simple_footnote_link show-tooltip type1\" title =\"Neue Zahlen zu Krebs in Deutschland\r\nPressemitteilung des Robert Koch-Instituts, Stand: 17.12.2019\" data-extlink=\"\" data-extlink_label=\"\">1<\/a><\/sup><\/span>SICHERHEIT QIMONO sch\u00fctzt vor EXPOSITIONEN Mit dem steigenden Einsatz von Zytostasen, auch f\u00fcr Indikationen au\u00dferhalb der Onkologie (z.B. rheumatische Erkrankungen), erh\u00f6ht sich auch das Expositionsrisiko f\u00fcr Mitarbeiter im Gesundheitswesen. Anforderungen an ein sicheres Applikationssystem Qimono macht das bestehende Infusionssystem sicherer, da es mit Standard Luer-Lock Systemen kompatibel ist und sowohl patientenseitig als auch infusionsseitig ein jederzeit geschlossenes System ist. Qimono Produkte Das Qimono Sicherheitsapplikationssystem ist ein sog. Closed Safety System for Administration (CSSA), das\u00a0 individuelle Sicherheitsl\u00f6sungen f\u00fcr den Umgang mit gesundheitsgef\u00e4hrdenden Substanzen bietet um die Mitarbeiter in der Klinik oder Ambulanz sowie Patienten und deren Angeh\u00f6rige vor den schwerwiegenden Folgen einer Zytostatika-Exposition \u00a0bestm\u00f6glich zu sch\u00fctzen. <span id=\"cmfSimpleFootnoteLink2-0\" class=\"cmf_has_footnote_custom\"><sup><a href=\"#cmfSimpleFootnoteLink2\" class=\"et_smooth_scroll_disabled cmf_simple_footnote_link show-tooltip type1\" title =\"Seth Eisenberg, Closed safety system for administration (CSSA): proposal for a new cytotoxic chemotherapy acronym, British Journal of Nursing, 2022, Vol 31, No 10 (Oncology Supplement)\" data-extlink=\"\" data-extlink_label=\"\">2<\/a><\/sup><\/span>Empfohlene Produkte \n<script>\n\/\/  window.loadMagentoProductsRoute = 'https:\/\/vygon-api.cekom.de\/products?skus=';\n\/\/  window.loadMagentoProductsRoute = 'https:\/\/vygon-api.cekom.de\/products?skus=10001,10002&catid=6'\n  window.loadMagentoProductsRoute = 'https:\/\/vygon-api.cekom.de\/products?skus=&catid=311'\n\/\/  window.loadMagentoProductsRoute = 'https:\/\/vygon-api.cekom.de\/products?sku=10323'\n<\/script>\n  <link href=\"https:\/\/www.vygon.de\/unternehmen\/wp-content\/plugins\/magento_products\/VygonProductSlider\/dist\/css\/app.8dd12db5.css\" rel=\"preload\" as=\"style\">\n  <link href=\"https:\/\/www.vygon.de\/unternehmen\/wp-content\/plugins\/magento_products\/VygonProductSlider\/dist\/css\/app.8dd12db5.css\" rel=\"stylesheet\">\n\n  <link href=\"https:\/\/www.vygon.de\/unternehmen\/wp-content\/plugins\/magento_products\/VygonProductSlider\/dist\/js\/app.0f767114.js\" rel=\"preload\" as=\"script\">  \n  <link href=\"https:\/\/www.vygon.de\/unternehmen\/wp-content\/plugins\/magento_products\/VygonProductSlider\/dist\/js\/chunk-vendors.f926f10c.js\" rel=\"preload\" as=\"script\">  \n\n<div id=\"app\"><\/div>\n\n<script src=\"https:\/\/www.vygon.de\/unternehmen\/wp-content\/plugins\/magento_products\/VygonProductSlider\/dist\/js\/app.0f767114.js\"><\/script>\n<script src=\"https:\/\/www.vygon.de\/unternehmen\/wp-content\/plugins\/magento_products\/VygonProductSlider\/dist\/js\/chunk-vendors.f926f10c.js\"><\/script>\n\n<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"page.php","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"<p>Test<\/p>","_et_gb_content_width":"","footnotes":""},"landingpage_category":[44],"class_list":["post-4135","hub_landingpages","type-hub_landingpages","status-publish","hentry","landingpage_category-onkologie"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Onkologie-Seite - Vygon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vygon.de\/unternehmen\/anwendungen\/onkologie-seite\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Onkologie-Seite - Vygon\" \/>\n<meta property=\"og:description\" content=\"SICHERHEITSSYSTEM F\u00dcR DIE APPLIKATION TOXISCHER ARZNEIMITTEL (SCHWERKRAFTINFUSION) SICHERHEITSSYSTEM F\u00dcR DIE APPLIKATION TOXISCHER ARZNEIMITTEL (INFUSIONSPUMPE)Dokumente hier direkt herunterladen in Deutschland 492.000 KREBSERKRANKUNGEN SICHERHEIT QIMONO sch\u00fctzt vor EXPOSITIONEN Mit dem steigenden Einsatz von Zytostasen, auch f\u00fcr Indikationen au\u00dferhalb der Onkologie (z.B. rheumatische Erkrankungen), erh\u00f6ht sich auch das Expositionsrisiko f\u00fcr Mitarbeiter im Gesundheitswesen. Anforderungen an ein sicheres Applikationssystem Qimono macht das bestehende Infusionssystem sicherer, da es mit Standard Luer-Lock Systemen kompatibel ist und sowohl patientenseitig als auch infusionsseitig ein jederzeit geschlossenes System ist. Qimono Produkte Das Qimono Sicherheitsapplikationssystem ist ein sog. Closed Safety System for Administration (CSSA), das\u00a0 individuelle Sicherheitsl\u00f6sungen f\u00fcr den Umgang mit gesundheitsgef\u00e4hrdenden Substanzen bietet um die Mitarbeiter in der Klinik oder Ambulanz sowie Patienten und deren Angeh\u00f6rige vor den schwerwiegenden Folgen einer Zytostatika-Exposition \u00a0bestm\u00f6glich zu sch\u00fctzen. Empfohlene Produkte\" \/>\n<meta property=\"og:site_name\" content=\"Vygon\" \/>\n<meta property=\"article:modified_time\" content=\"2022-11-15T13:48:12+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vygon.de\/unternehmen\/anwendungen\/onkologie-seite\/\",\"url\":\"https:\/\/www.vygon.de\/unternehmen\/anwendungen\/onkologie-seite\/\",\"name\":\"Onkologie-Seite - Vygon\",\"isPartOf\":{\"@id\":\"https:\/\/www.vygon.de\/unternehmen\/#website\"},\"datePublished\":\"2021-11-22T13:49:39+00:00\",\"dateModified\":\"2022-11-15T13:48:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vygon.de\/unternehmen\/anwendungen\/onkologie-seite\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vygon.de\/unternehmen\/anwendungen\/onkologie-seite\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vygon.de\/unternehmen\/anwendungen\/onkologie-seite\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.vygon.de\/unternehmen\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hubpages\",\"item\":\"https:\/\/www.vygon.de\/unternehmen\/anwendungen\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Onkologie-Seite\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vygon.de\/unternehmen\/#website\",\"url\":\"https:\/\/www.vygon.de\/unternehmen\/\",\"name\":\"Vygon\",\"description\":\"Sichere Medizinprodukte\",\"publisher\":{\"@id\":\"https:\/\/www.vygon.de\/unternehmen\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vygon.de\/unternehmen\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.vygon.de\/unternehmen\/#organization\",\"name\":\"Vygon Germany GmbH\",\"url\":\"https:\/\/www.vygon.de\/unternehmen\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/www.vygon.de\/unternehmen\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.vygon.de\/unternehmen\/wp-content\/uploads\/2021\/05\/Vygon-Logo.png\",\"contentUrl\":\"https:\/\/www.vygon.de\/unternehmen\/wp-content\/uploads\/2021\/05\/Vygon-Logo.png\",\"width\":224,\"height\":92,\"caption\":\"Vygon Germany GmbH\"},\"image\":{\"@id\":\"https:\/\/www.vygon.de\/unternehmen\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Onkologie-Seite - Vygon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vygon.de\/unternehmen\/anwendungen\/onkologie-seite\/","og_locale":"de_DE","og_type":"article","og_title":"Onkologie-Seite - Vygon","og_description":"SICHERHEITSSYSTEM F\u00dcR DIE APPLIKATION TOXISCHER ARZNEIMITTEL (SCHWERKRAFTINFUSION) SICHERHEITSSYSTEM F\u00dcR DIE APPLIKATION TOXISCHER ARZNEIMITTEL (INFUSIONSPUMPE)Dokumente hier direkt herunterladen in Deutschland 492.000 KREBSERKRANKUNGEN SICHERHEIT QIMONO sch\u00fctzt vor EXPOSITIONEN Mit dem steigenden Einsatz von Zytostasen, auch f\u00fcr Indikationen au\u00dferhalb der Onkologie (z.B. rheumatische Erkrankungen), erh\u00f6ht sich auch das Expositionsrisiko f\u00fcr Mitarbeiter im Gesundheitswesen. Anforderungen an ein sicheres Applikationssystem Qimono macht das bestehende Infusionssystem sicherer, da es mit Standard Luer-Lock Systemen kompatibel ist und sowohl patientenseitig als auch infusionsseitig ein jederzeit geschlossenes System ist. Qimono Produkte Das Qimono Sicherheitsapplikationssystem ist ein sog. Closed Safety System for Administration (CSSA), das\u00a0 individuelle Sicherheitsl\u00f6sungen f\u00fcr den Umgang mit gesundheitsgef\u00e4hrdenden Substanzen bietet um die Mitarbeiter in der Klinik oder Ambulanz sowie Patienten und deren Angeh\u00f6rige vor den schwerwiegenden Folgen einer Zytostatika-Exposition \u00a0bestm\u00f6glich zu sch\u00fctzen. Empfohlene Produkte","og_site_name":"Vygon","article_modified_time":"2022-11-15T13:48:12+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vygon.de\/unternehmen\/anwendungen\/onkologie-seite\/","url":"https:\/\/www.vygon.de\/unternehmen\/anwendungen\/onkologie-seite\/","name":"Onkologie-Seite - Vygon","isPartOf":{"@id":"https:\/\/www.vygon.de\/unternehmen\/#website"},"datePublished":"2021-11-22T13:49:39+00:00","dateModified":"2022-11-15T13:48:12+00:00","breadcrumb":{"@id":"https:\/\/www.vygon.de\/unternehmen\/anwendungen\/onkologie-seite\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vygon.de\/unternehmen\/anwendungen\/onkologie-seite\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.vygon.de\/unternehmen\/anwendungen\/onkologie-seite\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.vygon.de\/unternehmen\/"},{"@type":"ListItem","position":2,"name":"Hubpages","item":"https:\/\/www.vygon.de\/unternehmen\/anwendungen\/"},{"@type":"ListItem","position":3,"name":"Onkologie-Seite"}]},{"@type":"WebSite","@id":"https:\/\/www.vygon.de\/unternehmen\/#website","url":"https:\/\/www.vygon.de\/unternehmen\/","name":"Vygon","description":"Sichere Medizinprodukte","publisher":{"@id":"https:\/\/www.vygon.de\/unternehmen\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vygon.de\/unternehmen\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.vygon.de\/unternehmen\/#organization","name":"Vygon Germany GmbH","url":"https:\/\/www.vygon.de\/unternehmen\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.vygon.de\/unternehmen\/#\/schema\/logo\/image\/","url":"https:\/\/www.vygon.de\/unternehmen\/wp-content\/uploads\/2021\/05\/Vygon-Logo.png","contentUrl":"https:\/\/www.vygon.de\/unternehmen\/wp-content\/uploads\/2021\/05\/Vygon-Logo.png","width":224,"height":92,"caption":"Vygon Germany GmbH"},"image":{"@id":"https:\/\/www.vygon.de\/unternehmen\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.vygon.de\/unternehmen\/wp-json\/wp\/v2\/hub_landingpages\/4135","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vygon.de\/unternehmen\/wp-json\/wp\/v2\/hub_landingpages"}],"about":[{"href":"https:\/\/www.vygon.de\/unternehmen\/wp-json\/wp\/v2\/types\/hub_landingpages"}],"version-history":[{"count":1,"href":"https:\/\/www.vygon.de\/unternehmen\/wp-json\/wp\/v2\/hub_landingpages\/4135\/revisions"}],"predecessor-version":[{"id":5878,"href":"https:\/\/www.vygon.de\/unternehmen\/wp-json\/wp\/v2\/hub_landingpages\/4135\/revisions\/5878"}],"wp:attachment":[{"href":"https:\/\/www.vygon.de\/unternehmen\/wp-json\/wp\/v2\/media?parent=4135"}],"wp:term":[{"taxonomy":"landingpage_category","embeddable":true,"href":"https:\/\/www.vygon.de\/unternehmen\/wp-json\/wp\/v2\/landingpage_category?post=4135"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}